Cramer's 'Mad Money' Recap: Finding Market's Eternal Sunshine
03/05/07 - 07:44 PM EST
"It is our understanding that will be a five-year requirement," he continued. "That's the biggest we would ever see."
Further, despite Wachovia's worry that Ceradyne's peak margins can't get any better than they are, Moskowitz said they can. He said that the company's yields are improving and that he anticipates that they will continue to creep up with margin improvement. Cramer said he remains bullish on the stock. To view Cramer's interview with Joel Moskowitz, please click here.Lightning Round
Cramer was bullish on Savient Pharmaceuticals (SVNT Quote - Cramer on SVNT - Stock Picks), Express Scripts (ESRX Quote - Cramer on ESRX - Stock Picks), Alcoa (AA Quote - Cramer on AA - Stock Picks), Optium (OPTM Quote - Cramer on OPTM - Stock Picks), Level 3 Communications (LVLT Quote - Cramer on LVLT - Stock Picks), Bank of America (BAC Quote - Cramer on BAC - Stock Picks), Lamson & Sessions (LMS Quote - Cramer on LMS - Stock Picks) and Medtronic (MDT Quote - Cramer on MDT - Stock Picks). Cramer was bearish on CVS (CVS Quote - Cramer on CVS - Stock Picks), Cyberonics (CYBX Quote - Cramer on CYBX - Stock Picks) and JPMorgan Chase (JPM Quote - Cramer on JPM - Stock Picks). For more of Cramer's insights during the Lightning Round, click here.Want more Cramer? Check out Jim's rules and commandments for investing from his popular book by clicking here.
Sponsored by:



